Green Tea Extract (EGCG) for Antioxidant Protection

Green tea catechins, dominated by epigallocatechin gallate, are among the most potent radical scavengers measurable in vitro, and human trials do show improved plasma antioxidant capacity and reduced lipid peroxidation markers at roughly 300 to 600 mg EGCG daily over 8 to 12 weeks. The complication is that EGCG's real-world behaviour is more nuanced than the test tube suggests. Bioavailability is low, plasma half-life is short, and at high concentrations EGCG can behave as a pro-oxidant — which is directly relevant to the liver safety signal seen with concentrated extracts.

Brewed green tea delivers catechins at doses with a long history of safe use and is a reasonable default. Concentrated extracts reach the studied doses more conveniently but carry the bulk of the reported hepatotoxicity cases, particularly when taken fasted.

EGCG carries eight phenolic hydroxyl groups, giving it exceptional hydrogen-donating capacity against hydroxyl, superoxide and peroxyl radicals, and it chelates iron and copper, reducing Fenton-driven radical generation. Much of the iron chelation happens in the gut lumen, which is also why it can impair non-haem iron absorption.

Given the low plasma concentrations actually achieved, the more plausible route for sustained effect is hormetic signalling: EGCG activates Nrf2, upregulating endogenous glutathione peroxidase, superoxide dismutase and haem oxygenase-1, and inhibits NF-kappaB-driven inflammatory transcription. In other words, the supplement nudges the cell to make its own antioxidants rather than acting mainly as a scavenger itself. The same reactivity that makes EGCG effective at low concentrations makes it capable of generating hydrogen peroxide at high ones — the pro-oxidant crossover that underlies dose caution.

Take green tea extract with food. Fasted dosing raises peak EGCG concentrations substantially and is the pattern most associated with liver injury reports. European authorities have flagged doses at or above 800 mg EGCG per day from supplements as a hepatic concern, so staying below that is a sensible ceiling.

The relevant evidence is a group of randomised, placebo-controlled trials in healthy adults, smokers and people with metabolic syndrome, measuring plasma total antioxidant capacity, malondialdehyde and oxidised LDL. Direction of effect is broadly consistent at 300 to 600 mg EGCG daily, but trials are short and none tests clinical endpoints attributable to antioxidant activity.

Brewed green tea is very well tolerated. Concentrated extracts are a different risk profile: nausea, stomach discomfort and caffeine-related jitteriness are common, and rare but serious idiosyncratic liver injury has been documented, with most cases occurring on fasted high-dose extracts and resolving after stopping.

Green tea extract interacts through three routes: iron chelation in the gut, vitamin K content and mild antiplatelet effects, and caffeine load in non-decaffeinated products.